Novo Resources (NVO) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Novo Nordisk said to have contracted Ypsomed to make next gen obesity drug’s pensNovember 22 at 10:51 AM | msn.comNovo Nordisk Unusual Options Activity For November 19November 20 at 1:40 AM | benzinga.comNovo Sells Remaining Interest in Quartz Hill Joint VentureNovember 20 at 1:40 AM | markets.businessinsider.comNovo Nordisk shares jump 8% after Wegovy sales beat expectationsNovember 7, 2024 | msn.comForecasting The Future: 7 Analyst Projections For Novo NordiskNovember 7, 2024 | benzinga.comNovo Nordisk aware of 10 deaths related to weight-loss drug copies - reportNovember 6, 2024 | seekingalpha.comNovo Nordisk Stock Slips as Sales Grow Less Than ExpectedNovember 6, 2024 | investopedia.comNovo Nordisk Q3 Preview: Will $285 Million Weight Loss Bet Offset Bearish Charts?November 6, 2024 | benzinga.comNovo Nordisk's obesity-fighting drugs are fattening Denmark's economy while shrinking other sectorsNovember 3, 2024 | msn.comNovo's trial of weight-loss drug shows improvement in fatty liver diseaseNovember 1, 2024 | msn.comNovo Nordisk posts Phase 3 win for obesity drug in MASHNovember 1, 2024 | seekingalpha.comTaking A Look At Eli Lilly's Q3 2024 Revenue Miss Amid Supply Chain ChallengesOctober 30, 2024 | seekingalpha.comHims & Hers stock falls 14% after FDA changes semaglutide supply status (update)October 30, 2024 | msn.comNovo Resources Corp. - September Quarterly UpdateOctober 23, 2024 | markets.businessinsider.comNovo Holdings leads $112M investment in Watertown biotechOctober 22, 2024 | bizjournals.comNovo Resources Reports 2024 Sustainability ReportOctober 16, 2024 | markets.businessinsider.comJim Cramer: 'We Need More Uranium,' Recommends This Stock; Says Novo Nordisk 'Doesn't Hold A Candle' To Big Pharma RivalOctober 15, 2024 | benzinga.comNovo Resources farm-in partner De Grey Mining to continue aggressive exploration at Egina Gold ProjectOctober 10, 2024 | au.investing.comOzempic underworld: Inside the black market of obesity drugsOctober 9, 2024 | nbcnews.comDe Grey Reaches A$7M Minimum Spend at Egina Gold Project and Continues InvestmentOctober 9, 2024 | markets.businessinsider.comIs Novo Nordisk A/S (NYSE:NVO) The Top Global Stock To Buy Now?September 30, 2024 | msn.comNovo Resources to Present at the Battery and Precious Metals Virtual Investor Conference OctoberSeptember 30, 2024 | markets.businessinsider.comOzempic and Wegovy drugmaker treating US as its 'cash cow', Sanders saysSeptember 25, 2024 | bbc.co.ukViking Therapeutics Is A Buy For Some Investors, But Beware The Sizeable RisksSeptember 25, 2024 | seekingalpha.comPopular Ozempic May Have New Use As Semaglutide Drugs Linked To Reduced Overdose Risk In Diabetic Opioid UsersSeptember 25, 2024 | benzinga.comLose Weight With Novo Nordisk Drugs, Gain Money With StockSeptember 25, 2024 | benzinga.comBelltopper Gold Project VideoSeptember 25, 2024 | markets.businessinsider.comSenate HELP Committee hearing could get heated as Novo Nordisk CEO testifiesSeptember 24, 2024 | msn.comNovo Nordisk's Options: A Look at What the Big Money is ThinkingSeptember 24, 2024 | benzinga.comNovo Nordisk's experimental weight loss pill has some concerning side effectsSeptember 21, 2024 | msn.comSanders says generic drugmakers could sell Novo Nordisk Ozempic for less than $100September 20, 2024 | seekingalpha.comInnovationRx: FDA Commissioner Talks Healthcare AISeptember 19, 2024 | forbes.comAre We Thinking About Obesity All Wrong?September 19, 2024 | nytimes.comNoom launches cheaper compounded version of Novo's semaglutideSeptember 12, 2024 | msn.comEvaluation of Pilbara Antimony-Gold Potential Generates Positive ResultsSeptember 12, 2024 | markets.businessinsider.comNovo Resources identifies antimony-gold potential at Pilbara landholdingSeptember 12, 2024 | au.investing.comNovo Resources: Evaluation of Pilbara Antimony-Gold Potential Generates Positive ResultsSeptember 12, 2024 | juniorminingnetwork.comNovo Nordisk rises after full data for new weight loss pillSeptember 11, 2024 | msn.comNovo Nordisk: Low Dividend Yield, Decelerated Growth Rates, Hold For NowSeptember 10, 2024 | seekingalpha.comNovo to present at the Resources Rising Stars Gold Coast Investor ConferenceSeptember 2, 2024 | financialpost.comNovo highlights heart benefits of weight loss drug with new analysisSeptember 1, 2024 | msn.comNovo Resources Corp.: Nunyerry North High-Grade Gold Zone Extended and Egina Gold Camp Exploration Targets AdvancedAugust 29, 2024 | finanznachrichten.deCatalent beats revenue estimates ahead of deal close with Novo HoldingsAugust 29, 2024 | yahoo.comNunyerry North High-Grade Gold Zone Extended and Egina Gold Camp Exploration Targets AdvancedAugust 29, 2024 | markets.businessinsider.comMedicare coverage of Novo Nordisk's Wegovy could cost up to $145B annuallyAugust 28, 2024 | seekingalpha.comSignificant Results From Historical Drill Hole Infill Assay Program at BelltopperAugust 22, 2024 | markets.businessinsider.comNovo Resources: Significant Results From Historical Drill Hole Infill Assay Program at BelltopperAugust 22, 2024 | juniorminingnetwork.comNovo Resources DRC (NVO) Earnings Dates & ReportsAugust 13, 2024 | investing.comNovo Resources: Top 10 Undervalued Nano Cap Stocks on TSX (NVO)August 11, 2024 | theglobeandmail.comEuropean Stocks: Novo Nordisk Lowers Profit Outlook on Subdued Wegovy SalesAugust 9, 2024 | nasdaq.com Get Novo Resources News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Email Address A “Thank You Gift” From Pres. Trump - Genius (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics… Get Your Free Gold Guide NVO Media Mentions By Week NVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVO News Sentiment▼0.310.56▲Average Basic Materials News Sentiment NVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVO Articles This Week▼33▲NVO Articles Average Week Get Novo Resources News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 4Front Ventures News Today Algernon Pharmaceuticals News Today Allstar Health Brands News Today Alvotech News Today American Premium Mining News Today Anew Medical News Today Arno Therapeutics News Today AstraZeneca News Today AVVAA World Health Care Products News Today Basilea Pharmaceutica News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:NVO) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Resources Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Resources With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.